May 6, 2020 / 3:07 AM / a month ago

BRIEF-Igea Pharma Says Miami University Confirms 'High Quality' Of Igea's COVID-19 Rapid Test

May 5 (Reuters) - IGEA Pharma NV:

* MIAMI UNIVERSITY CONFIRMS HIGH QUALITY OF IGEA’S COVID-19 RAPID TEST

* EVALUATION BY UNIVERSITY OF MIAMI SUGGESTS IGEA’S COVID-19 ANTIBODY RAPID TEST APPEARS TO BE SUPERIOR IN DETECTING IGM AND IGG ANTIBODIES

* OVERALL HIGHER SENSITIVITY OF IGEA’S RAPID TEST OVER ELISA PROCEDURE USED OBSERVED USING RT PCR TEST COMPARISON FOR SAME SPECIMENS

* PCR RESULTS COMPARISON COULD SUGGEST SUITABILITY IN USING ANTIBODY-BASED TEST EVEN IN EARLY STAGES OF INFECTION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below